baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

TERUMO CORP./ JP3546800008 /

6/27/2024 8:05:28 AM	Chg. 0.0000	Volume	Bid8:05:30 AM	Ask8:05:30 AM	Market Capitalization	Dividend Y.	P/E Ratio
15.2000EUR	0.00%	0 Turnover: 0.0000	15.2000Bid Size: 400	15.5000Ask Size: 400	11.43 bill.EUR	-	-

GlobeNewswire 6/10 Over 80 Organizations Kick Off Blood Advocacy Week by Urging Congress to Support the Blood Supply as...

GlobeNewswire 6/4 Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Le...

GlobeNewswire 5/22 Orchestra BioMed to Participate in Jefferies Global Healthcare Conference

GlobeNewswire 5/13 Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire 5/9 R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...

GlobeNewswire 4/30 Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Paten...

GlobeNewswire 4/30 Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacem...

GlobeNewswire 4/2 Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives

GlobeNewswire 3/26 Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of D...

GlobeNewswire 3/13 Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy ...

GlobeNewswire 3/7 Orchestra BioMed to Participate in Upcoming Investor Conferences

GlobeNewswire 3/6 Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemod...

GlobeNewswire 2/26 Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambu...

GlobeNewswire 2/20 TransPerfect’s GlobalLink/Adobe Experience Manager (AEM) Integration Adds 30+ Global Brands in 2023

GlobeNewswire 1/8 Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pace...

GlobeNewswire 11/13/2023 Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire 11/9/2023 Orchestra BioMed to Present at Upcoming Investor Conferences

GlobeNewswire 9/19/2023 Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for...

GlobeNewswire 8/24/2023 NeurAxis Highlights Strength of its Board of Directors

GlobeNewswire 2/3/2022 Applied Science, Inc. Announces New Vice President of Sales, Marketing & Customer Care, Ral Trujillo

GlobeNewswire 12/17/2021 Sigyn Therapeutics CEO Note: As Omicron Surges, Consider That the First Authorized COVID-19 Therapie...

GlobeNewswire 11/18/2021 Terumo Corporation and Diabeloop SA Enter Into Comprehensive Strategic Partnership Agreement to Expa...

GlobeNewswire 11/5/2021 Orchestra BioMed™ Announces Presentations at TCT 2021 of Positive Long-Term Clinical Results from th...

GlobeNewswire 8/17/2021 Orchestra BioMed™ Announces Peer-Reviewed Publication of MODERATO II Study Results Showing a Statist...

GlobeNewswire 7/30/2021 Orchestra BioMed™ Announces Clinical Data Demonstrating a Significant and Sustained Reduction in Blo...

TERUMO CORP./ JP3546800008 /

If you wish to receive reply to your feedback, please provide your email address.